186 related articles for article (PubMed ID: 37204665)
21. An integrative approach for exploring the nature of fibroepithelial neoplasms.
Yun J; Heo W; Lee ES; Na D; Kang W; Kang J; Chae J; Lee D; Lee W; Hwang J; Yoo TK; Hong BS; Son HY; Noh DY; Lee C; Moon HG; Kim JI
Br J Cancer; 2023 Feb; 128(4):626-637. PubMed ID: 36522480
[TBL] [Abstract][Full Text] [Related]
22. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.
Barth RJ
Breast Cancer Res Treat; 1999 Oct; 57(3):291-5. PubMed ID: 10617306
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast.
Parkes A; Wang WL; Patel S; Leung CH; Lin H; Conley AP; Somaiah N; Araujo DM; Zarzour M; Livingston JA; Ludwig J; Roland CL; Ravi V; Benjamin RS; Ratan R
Breast Cancer Res Treat; 2021 Apr; 186(3):871-882. PubMed ID: 33575859
[TBL] [Abstract][Full Text] [Related]
24. Fine-needle sampling in malignant phyllodes tumors: clinicopathologic study of 22 cases seen at the Institut Curie.
Vladescu T; Klijanienko J; Caillaud JM; Lagacé R; Vielh P
Diagn Cytopathol; 2004 Aug; 31(2):71-6. PubMed ID: 15282716
[TBL] [Abstract][Full Text] [Related]
25. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
26. [Which chemotherapy regimen in patients with metastatic phyllodes tumors of the breast? case report].
Kaikai IA; Bourhafour M; Haffadi M; Bouchbika Z; Benchakroune N; Jouhadi H; Tawfiq N; Sahraoui S; Benider A
Pan Afr Med J; 2022; 42():293. PubMed ID: 36415336
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
28. Malignant phyllodes tumor of the breast: a systematic review.
Lissidini G; Mulè A; Santoro A; Papa G; Nicosia L; Cassano E; Ashoor AA; Veronesi P; Pantanowitz L; Hornick JL; Rossi ED
Pathologica; 2022 Apr; 114(2):111-120. PubMed ID: 35414723
[TBL] [Abstract][Full Text] [Related]
29. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
30. Factors effective on recurrence and metastasis in phyllodes tumors.
Altiok M; Kurt F
Niger J Clin Pract; 2022 Apr; 25(4):425-431. PubMed ID: 35439900
[TBL] [Abstract][Full Text] [Related]
31. Malignant phyllodes tumors of the breast: A comprehensive literature review.
Papas Y; Asmar AE; Ghandour F; Hajj I
Breast J; 2020 Feb; 26(2):240-244. PubMed ID: 31478587
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous presentation of a distant metastasis of malignant phyllodes tumor.
Swapp RE; Shon W; Peethambaram PP; Moran SL; Reynolds C
Int J Dermatol; 2012 Jan; 51(1):72-4. PubMed ID: 22182382
[No Abstract] [Full Text] [Related]
33. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.
Wang F; Jia Y; Tong Z
Jpn J Clin Oncol; 2015 Feb; 45(2):146-52. PubMed ID: 25387733
[TBL] [Abstract][Full Text] [Related]
35. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
36. Malignant phyllodes tumour of the breast.
Badar F; Mahmood S; Syed AA; Siddiqui N
J Ayub Med Coll Abbottabad; 2012; 24(3-4):47-9. PubMed ID: 24669607
[TBL] [Abstract][Full Text] [Related]
37. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
Takada K; Aizawa Y; Sano D; Okuda R; Sekine K; Ueno Y; Yamanaka S; Aoyama J; Sato K; Kuwahara T; Hatano T; Takahashi H; Arai Y; Nishimura G; Taniguchi H; Oridate N
Int J Cancer; 2021 Jan; 148(1):193-202. PubMed ID: 32984947
[TBL] [Abstract][Full Text] [Related]
38. Metastatic phyllodes tumor causing small-bowel obstruction.
Kelly RJ; Barrett C; Swan N; McDermott R
Clin Breast Cancer; 2009 Aug; 9(3):193-5. PubMed ID: 19661046
[TBL] [Abstract][Full Text] [Related]
39. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
[TBL] [Abstract][Full Text] [Related]
40. Phyllodes tumors of the breast: Analysis of 35 cases from a single institution.
Demian GA; Fayaz S; El-Sayed Eissa H; Nazmy N; Samir S; George T; El-Sherify M; Abuzalouf S
J Egypt Natl Canc Inst; 2016 Dec; 28(4):243-248. PubMed ID: 27406381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
